For its fourth fiscal quarter (ending December 31), Perion Network Ltd (NASDAQ: PERI) has reported a -87% decline in E.P.S. from $0.83 a year ago to $0.11 in the current quarter. E.P.S. were $0.27 for […]
Penumbra Inc (NYSE: PEN) stock closed at $303.76 on 2/19/25 after a major increase of 12.0%. Moreover, this advance was accompanied by exceptionally high trading volume at 388% of normal. The stock has been exceptionally […]
Orion Engineered Carbons SA (NYSE: OEC) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.30 versus $0.08 for the same period a year ago — an increase of 275%. For the […]
OGE ENERGY CORP (NYSE: OGE) has reported E.P.S. of $0.51 for its fourth fiscal quarter (ending December 31) versus $0.24 for the same period a year ago — an increase of 112%. For the latest […]
Nutrien Ltd (NYSE: NTR) has reported E.P.S. of $0.23 for its fourth fiscal quarter (ending December 31) versus $0.35 for the same period a year ago — a decline of -34%. For the latest four […]
Northern Oil and Gas Inc (NYSE: NOG) has reported E.P.S. of $0.72 for its fourth fiscal quarter (ending December 31) versus $3.92 for the same period a year ago — a decline of -82%. For […]
Koninklijke Philips NV (NYSE: PHG) stock closed at $25.05 on 2/19/25 after a major decline of -11.5%. Moreover, this decline was accompanied by exceptionally high trading volume at 449% of normal. The stock has declined […]
Icon PLC (NASDAQ: ICLR) has reported earnings for its fourth fiscal quarter (ending December 31) of $3.18 versus $2.63 for the same period a year ago — an increase of 21%. For the latest four […]
On 2/19/25, B. Riley Financial Inc (NASDAQ: RILY) stock suffered a major decline of -11.1%, closing at $3.41. Moreover, trading volume in this decline was unusually high at 190% of normal. Relative to the market […]
For its fourth fiscal quarter (ending December 31), Amicus Therapeutics Inc (NASDAQ: FOLD) has reported a -145% decline in E.P.S. from $-0.11 a year ago to $0.05 in the current quarter. For the latest four […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research